Squamous Cell Differentiation in Metastatic Papillary Thyroid Carcinoma: Metaplastic Reversion or Progression?

Area of Science:

• Oncology
• Pathology
• Molecular Biology

Background:

• Papillary thyroid carcinoma (PTC) typically exhibits follicular cell differentiation.
• Squamous cell differentiation (SCD) in PTC is rare and often associated with metastatic sites.
• Understanding the molecular markers of SCD in PTC is crucial for diagnosis and prognosis.

Observation:

• A 21-year-old patient with bilateral PTC and neck lymph node metastases was analyzed.
• Metastases showed cystic changes and focal squamous cell differentiation (SCD).
• Immunohistochemical analysis included cytokeratin CK5/6, P63, thyroid transcription factor 1 (TTF1), and B-Raf.

Findings:

• PTC expressed P63 focally, and TTF1 and B-Raf diffusely.
• CK5/6 was expressed in lymph node metastases and SCD foci, but not in the primary PTC.
• TTF1 expression was faint in SCD, while B-Raf was expressed in both classical PTC and SCD epithelia.

Implications:

• Expression patterns of CK5/6, P63, and TTF1 suggest a differentiation direction for SCD within PTC metastases.
• The development of SCD in PTC metastases may represent a metaplastic change.
• Further research is needed to determine if SCD indicates tumor regression or progression towards squamous cell carcinoma.